Trials / Conditions / Extranodal Natural Killer T Cell Lymphoma
Extranodal Natural Killer T Cell Lymphoma
5 registered clinical trials studyying Extranodal Natural Killer T Cell Lymphoma — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Sintilimab and Linperlisib Combination Treatment in Relapsed or Refractory Extranodal Natural Killer/T Cell Ly NCT06793956 | Sun Yat-sen University | Phase 1 |
| Not Yet Recruiting | The Efficacy and Safety of Chidamide, Anti-PD-1 Antibody in Combination With Pegaspargase Versus DDGP in the T NCT06255795 | Ruijin Hospital | Phase 3 |
| Active Not Recruiting | Tislelizumab Combined with Mitoxantrone Hydrochloride Liposome in Extranodal Natural Killer/T Cell Lymphoma NCT05464433 | Sun Yat-sen University | Phase 1 / Phase 2 |
| Not Yet Recruiting | A Clinical Study of the Value of Circulating Free Methylated EBV DNA in Extranodal NK/T Cell Lymphoma NCT05343377 | The First Affiliated Hospital with Nanjing Medical University | N/A |
| Completed | A Study of CS1001 in Subjects With Relapsed or Refractory Extranodal Natural Killer/ T Cell Lymphoma(ENKTL) NCT03595657 | CStone Pharmaceuticals | Phase 2 |